Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Director Sells $282,549.36 in Stock
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) Director Catherine Moukheibir sold 44,426 shares of the stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $6.36, for a total transaction of $282,549.36. Following the completion of the sale, the director now owns 84,207 shares of the company’s […]
More Stories
Wealth Enhancement Advisory Services LLC Trims Stock Position in iShares 0-3 Month Treasury Bond ETF (NYSEARCA:SGOV)
Wealth Enhancement Advisory Services LLC lowered its stake in shares of iShares 0-3 Month Treasury Bond ETF (NYSEARCA:SGOV – Free...
Lockheed Martin Co. (NYSE:LMT) Shares Bought by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC lifted its stake in shares of Lockheed Martin Co. (NYSE:LMT – Free Report) by 0.6%...
Wealth Enhancement Advisory Services LLC Purchases 680,584 Shares of Schwab Intermediate-Term U.S. Treasury ETF (NYSEARCA:SCHR)
Wealth Enhancement Advisory Services LLC raised its position in Schwab Intermediate-Term U.S. Treasury ETF (NYSEARCA:SCHR – Free Report) by 64.1%...
Devon Energy Co. (NYSE:DVN) Shares Sold by Hilltop National Bank
Hilltop National Bank lessened its stake in Devon Energy Co. (NYSE:DVN – Free Report) by 3.9% in the 4th quarter,...
The PNC Financial Services Group, Inc. (NYSE:PNC) Shares Sold by ST Germain D J Co. Inc.
ST Germain D J Co. Inc. reduced its position in The PNC Financial Services Group, Inc. (NYSE:PNC – Free Report)...
Alphabet (NASDAQ:GOOGL) Given New $225.00 Price Target at KeyCorp
Alphabet (NASDAQ:GOOGL – Free Report) had its target price lifted by KeyCorp from $215.00 to $225.00 in a report released...